Harbour Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Harbour Investments's NVO Position: Q1 2026 in Review
Harbour Investments increased its Novo Nordisk (NVO) stake by 266% in Q1 2026, buying an estimated $819K and bringing the position to 23,784 shares worth $874K. The position accounts for 0.01% of the portfolio, ranked #816.
Harbour Investments first reported a position in NVO in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.67M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Harbour Investments held 23,784 shares of Novo Nordisk worth $874K as of Q1 2026.
- Harbour Investments bought 17,280 Novo Nordisk shares in Q1 2026, an estimated $819K.
- Novo Nordisk made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #816 holding.
- Harbour Investments first reported a position in Novo Nordisk in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's Novo Nordisk position peaked at $1.67M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.